Duloxetine as a gut-brain axis modulator in irritable bowel syndrome: neuroimmune, microbiota, and pharmacogenomic perspectives
- DOI
- 10.1007/s00210-026-05419-1
- Published
- 2026-05-22
- Container
- Naunyn-Schmiedeberg's Archives of Pharmacology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00210-026-05419-1,
title = {Duloxetine as a gut-brain axis modulator in irritable bowel syndrome: neuroimmune, microbiota, and pharmacogenomic perspectives},
author = {Mokhtar Rejili and Aya M. Mustafa and Hayder M. Al-kuraishy and Nawar R. Hussein and Thabat J. Al-Maiahy and Ali I. Al-Gareeb and Ali K. Albuhadily and Gaber El-Saber Batiha},
year = {2026},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
doi = {10.1007/s00210-026-05419-1},
url = {https://doi.org/10.1007/s00210-026-05419-1}
}RIS
TY - JOUR TI - Duloxetine as a gut-brain axis modulator in irritable bowel syndrome: neuroimmune, microbiota, and pharmacogenomic perspectives AU - Mokhtar Rejili AU - Aya M. Mustafa AU - Hayder M. Al-kuraishy AU - Nawar R. Hussein AU - Thabat J. Al-Maiahy AU - Ali I. Al-Gareeb AU - Ali K. Albuhadily AU - Gaber El-Saber Batiha PY - 2026 JO - Naunyn-Schmiedeberg's Archives of Pharmacology DO - 10.1007/s00210-026-05419-1 UR - https://doi.org/10.1007/s00210-026-05419-1 ER -
APA
Rejili, M., Mustafa, A. M., Al-kuraishy, H. M., Hussein, N. R., Al-Maiahy, T. J., Al-Gareeb, A. I., Albuhadily, A. K., & Batiha, G. E. (2026). Duloxetine as a gut-brain axis modulator in irritable bowel syndrome: neuroimmune, microbiota, and pharmacogenomic perspectives. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05419-1
Source records
- crossref · retrieved 2026-11-04T02:58:22.662Z